Calumet Specialty Products Partners (CLMT) Stock Price, News & Analysis

Company Overview

Calumet, Inc. manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to various consumer-facing and industrial markets in North America and internationally. It operates through Specialty Products and Solutions; Montana/Renewables; and Performance brands segments. The Specialty Products and Solutions segment offers various solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and other products. The Montana/Renewables segment focuses on processing renewable feedstocks into renewable diesel, sustainable aviation fuel, renewable hydrogen, renewable natural gas, renewable propane, and renewable naphtha. It also processes Canadian crude oil into conventional gasoline, diesel, jet fuel, and specialty grades of asphalt. The Performance Brands segment blends, packages, and markets high performance products through Royal Purple, Bel-Ray, and TruFuel brands. The company serves wholesale distributors and retail chains. Calumet, Inc. was founded in 1919 and is headquartered in Indianapolis, Indiana.

Key Stats

• Today's Range: $20.46 to $21.71
• 50-Day Range: $15.03 to $22.25
• 52-Week Range: $9.97 to $25.29
• Volume: 735,939 shs
• Average Volume: 817,315 shs
• Market Capitalization: $1.80 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $23.75
• Consensus Rating: Buy

Calumet Specialty Products Partners Stock Analysis - MarketRank™

Calumet Specialty Products Partners scored higher than 26% of companies evaluated by MarketBeat, and ranked 236th out of 265 stocks in the oils/energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.5 / 5
• Analyst Rating: Buy

Consensus Rating

Calumet Specialty Products Partners has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Calumet Specialty Products Partners has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Calumet Specialty Products Partners are expected to grow in the coming year, from ($2.87) to ($0.22) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Calumet Specialty Products Partners is -7.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Calumet Specialty Products Partners is -7.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

7.93% of the float of Calumet Specialty Products Partners has been sold short.

Short Interest Ratio / Days to Cover

Calumet Specialty Products Partners has a short interest ratio ("days to cover") of 6.2.

Change versus previous month

Short interest in Calumet Specialty Products Partners has recently decreased by 3.20%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Calumet Specialty Products Partners does not currently pay a dividend.

Dividend Growth

Calumet Specialty Products Partners does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

7.93% of the float of Calumet Specialty Products Partners has been sold short.

Short Interest Ratio / Days to Cover

Calumet Specialty Products Partners has a short interest ratio ("days to cover") of 6.2.

Change versus previous month

Short interest in Calumet Specialty Products Partners has recently decreased by 3.20%, indicating that investor sentiment is improving.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: -0.02

News Sentiment

Calumet Specialty Products Partners has a news sentiment score of -0.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Oils/Energy companies.

News Coverage This Week

MarketBeat has tracked 20 news articles for Calumet Specialty Products Partners this week, compared to 3 articles on an average week.

Search Interest

1 people have searched for CLMT on MarketBeat in the last 30 days.

MarketBeat Follows

8 people have added Calumet Specialty Products Partners to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Calumet Specialty Products Partners insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,059,000.00 in company stock.

Percentage Held by Insiders

Only 2.91% of the stock of Calumet Specialty Products Partners is held by insiders.

Percentage Held by Institutions

Only 34.41% of the stock of Calumet Specialty Products Partners is held by institutions.

CLMT Stock Analysis - Frequently Asked Questions

How have CLMT shares performed this year?

Calumet Specialty Products Partners' stock was trading at $17.87 on January 1st, 2024. Since then, CLMT shares have increased by 17.1% and is now trading at $20.92.
View the best growth stocks for 2024 here.

How were Calumet Specialty Products Partners' earnings last quarter?

Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) posted its quarterly earnings data on Friday, November, 8th. The oil and gas company reported ($1.18) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.59) by $0.59. The company's revenue for the quarter was down 4.3% on a year-over-year basis.

Does Calumet Specialty Products Partners have any subsidiaries?

Calumet Specialty Products Partners subsidiaries include Biosynthetic Technologies, Specialty Oil Field Solutions, Anchor Drilling Fluids USA, United Petroleum Company, Bel-Ray, Montana Renewables, Royal Purple, and others.

Who are Calumet Specialty Products Partners' major shareholders?

Calumet Specialty Products Partners' top institutional investors include Jane Street Group LLC, Wolverine Trading LLC and Valeo Financial Advisors LLC (0.05%). Insiders that own company stock include Jennifer Straumins, James S Carter, Scott Obermeier, Stephen P Mawer, Daniel J Sajkowski, Louis Todd Borgmann, Gregory J Morical and Ryan Willman.
View institutional ownership trends.

How do I buy shares of Calumet Specialty Products Partners?

Shares of CLMT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Calumet Specialty Products Partners own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Calumet Specialty Products Partners investors own include Chembio Diagnostics (CEMI), Prospect Capital (PSEC), Two Harbors Investment (TWO), BlackRock Capital Investment (BKCC), NovoCure (NVCR), Viper Energy (VNOM) and Summit Midstream Partners (SMLP).

Company Calendar

• Last Earnings: 11/08/2024
• Today: 11/17/2024
• Fiscal Year End: 12/31/2024
• Next Earnings (Estimated): 2/28/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Oils/Energy
• Industry: Petroleum refining
• Sub-Industry: Petroleum And Natural Gas
• Current Symbol: NASDAQ:CLMT
• CUSIP: N/A
• CIK: 1340122
• Web: www.calumetspecialty.com
• Phone: (317) 328-5660
• Fax: 317-328-2359
• Employees: 1,580
• Year Founded: 1916

Price Target and Rating

• Average Stock Price Target: $23.75
• High Stock Price Target: $29.00
• Low Stock Price Target: $15.00
• Potential Upside/Downside: +13.5%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 4 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($2.76)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $48.10 million
• Net Margins: -5.42%
• Pretax Margin: -5.40%
• Return on Equity: N/A
• Return on Assets: -8.19%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.63
• Quick Ratio: 0.33

Sales & Book Value

• Annual Sales: $4.18 billion
• Price / Sales: 0.43
• Cash Flow: $1.19 per share
• Price / Cash Flow: 17.61
• Book Value: ($7.83) per share
• Price / Book: -2.67

Miscellaneous

• Outstanding Shares: 85,890,000
• Free Float: 83,394,000
• Market Cap: $1.80 billion
• Optionable: Optionable
• Beta: 1.90